SPCC1494.09c Antibody

What is SPCC1494.09c and what cellular processes is it involved in?

SPCC1494.09c is a protein-coding gene in Schizosaccharomyces pombe (fission yeast). While specific information about this particular gene is limited in the provided search results, fission yeast proteins are often studied in the context of fundamental cellular processes including cell cycle regulation, stress response pathways, and chromatin organization. Antibodies targeting these proteins are essential tools for investigating their expression, localization, and function through techniques like Western blotting, immunoprecipitation, and immunofluorescence microscopy . When designing experiments with SPCC1494.09c antibody, researchers should first validate the antibody's specificity through control experiments comparing wild-type and deletion strains.

What are the recommended applications for SPCC1494.09c antibody in fission yeast research?

SPCC1494.09c antibody can be employed in multiple experimental approaches common to S. pombe research. Western blotting is frequently used to detect the protein's expression levels and potential post-translational modifications, as demonstrated with similar fission yeast proteins . Chromatin immunoprecipitation (ChIP) can be performed to identify genomic binding sites if SPCC1494.09c functions as a chromatin-associated protein . For protein interaction studies, co-immunoprecipitation experiments would allow researchers to identify binding partners. Additionally, immunofluorescence microscopy can determine subcellular localization patterns, which is particularly informative when studying protein function in diverse cellular contexts.

How do I validate the specificity of a SPCC1494.09c antibody?

Antibody validation is critical for ensuring experimental reliability. The gold standard for validating SPCC1494.09c antibody specificity is comparing immunoblot results between wild-type S. pombe extracts and those from SPCC1494.09c deletion mutants (if viable) . Expected protein size should be confirmed against molecular weight markers. Cross-reactivity assessment with closely related proteins is recommended, particularly if SPCC1494.09c belongs to a protein family with conserved domains. For polyclonal antibodies, pre-immune serum should be tested as a negative control. Additionally, peptide competition assays, where the antibody is pre-incubated with purified antigen before use, can verify binding specificity by demonstrating signal reduction .

What are the optimal conditions for using SPCC1494.09c antibody in Western blotting?

For Western blotting with SPCC1494.09c antibody in S. pombe research, protein extraction should be performed using either mechanical disruption (glass beads) or enzymatic methods (zymolyase treatment) followed by TCA precipitation to preserve protein integrity . A recommended starting dilution for primary antibody incubation is 1:1000 in 5% BSA/TBST buffer, with overnight incubation at 4°C. For protein loading normalization, TAT-1 antibody (targeting α-tubulin) at 1:5000 dilution serves as an effective control . SDS-PAGE separation should be optimized based on SPCC1494.09c's predicted molecular weight, with 10-12% gels typically suitable for most S. pombe proteins. PVDF membranes often provide better results than nitrocellulose for fission yeast proteins. Signal detection can be performed using HRP-conjugated secondary antibodies with enhanced chemiluminescence (ECL) systems.

How should SPCC1494.09c antibody be used for chromatin immunoprecipitation (ChIP) experiments?

For ChIP applications with SPCC1494.09c antibody, cells should be crosslinked with 1% formaldehyde for 15 minutes at room temperature, followed by quenching with glycine . Chromatin shearing should be optimized to generate fragments between 200-500bp, typically achieved through sonication. Unlike some protocols, pre-clearing with Protein A Dynabeads may be omitted as noted in similar experiments with histone modification antibodies . For immunoprecipitation, 2-5μg of SPCC1494.09c antibody should be incubated with sheared chromatin overnight at 4°C, followed by capture with Protein A/G beads. After stringent washing, crosslink reversal, and DNA purification, enrichment can be assessed by qPCR or sequencing. Including both positive controls (regions predicted to bind SPCC1494.09c) and negative controls (regions unlikely to be bound) is essential for result interpretation.

What is the recommended protocol for generating custom SPCC1494.09c antibody?

Generating a custom SPCC1494.09c antibody follows a standard procedure similar to that used for other S. pombe proteins. The process begins with cloning the entire SPCC1494.09c coding region or selected peptide sequences into an appropriate expression vector like pET-30-a, which adds a His-tag for purification . After expressing the recombinant protein in E. coli (strains like Tuner are commonly used), purification can be performed using metal affinity chromatography systems such as MagneHis . The purified protein is then used to immunize rabbits or other suitable animals, typically through a prime-boost regimen over several months. Serum collection and antibody purification through antigen-specific affinity chromatography yields the final antibody preparation. Quality control should include ELISA assays to determine titer and Western blotting against S. pombe extracts to confirm specificity.

How can I address weak or absent signal when using SPCC1494.09c antibody in Western blots?

When encountering weak or absent signals with SPCC1494.09c antibody, multiple factors should be systematically evaluated. First, protein extraction methods should be optimized as S. pombe cell walls are notoriously difficult to break; mechanical disruption with glass beads in the presence of protease inhibitors often provides the best results . If protein degradation is suspected, TCA precipitation can help preserve integrity. Antibody concentration should be incrementally increased (1:500 to 1:100) while extending incubation times to overnight at 4°C. Enhanced detection systems (high-sensitivity ECL substrates) can improve signal detection. If the protein is expressed at low levels, enrichment through immunoprecipitation prior to Western blotting may be necessary. Finally, consider experimental conditions that might affect SPCC1494.09c expression, such as growth phase, nutritional status, or stress conditions that could regulate protein levels .

How do I interpret and troubleshoot multiple bands detected by SPCC1494.09c antibody?

Multiple bands detected by SPCC1494.09c antibody require careful analysis to determine whether they represent authentic biological variation or technical artifacts. First, compare observed bands with predicted molecular weights and consider potential post-translational modifications (phosphorylation, SUMOylation, etc.) that may alter migration patterns . Alternative splice variants, though less common in S. pombe than in metazoans, should be investigated through transcript analysis. To distinguish non-specific binding, perform peptide competition assays by pre-incubating the antibody with purified antigen . If using polyclonal antibodies, additional purification through affinity techniques may reduce background. For definitive identification of ambiguous bands, mass spectrometry analysis of immunoprecipitated material can confirm the presence of SPCC1494.09c peptides. Finally, genetic approaches using tagged versions of SPCC1494.09c can provide complementary evidence regarding authentic protein migration patterns.

How can I design experiments to study the dynamics of SPCC1494.09c during cell cycle progression?

To investigate SPCC1494.09c dynamics throughout the cell cycle, researchers should implement synchronized cell populations using established methods such as nitrogen starvation-release, hydroxyurea block-release, or lactose gradient centrifugation . Time-course sampling at 15-20 minute intervals followed by Western blotting with SPCC1494.09c antibody can reveal expression patterns, while co-probing for cell cycle markers (e.g., Cdc13/Cyclin B) confirms synchronization efficiency. For localization studies, immunofluorescence microscopy with SPCC1494.09c antibody combined with DNA staining (DAPI) and spindle visualization (anti-tubulin) enables correlation of protein distribution with specific cell cycle stages. More sophisticated approaches include chromatin immunoprecipitation sequencing (ChIP-seq) at different cell cycle points if SPCC1494.09c associates with DNA, or proximity-dependent biotin identification (BioID) to capture cell cycle-specific protein interactions. Temperature-sensitive cell cycle mutants can provide additional insights into which cell cycle phases require SPCC1494.09c function.

What approaches can be used to study post-translational modifications of SPCC1494.09c?

Post-translational modifications (PTMs) of SPCC1494.09c can be investigated through complementary approaches. Phosphorylation can be detected through phospho-specific antibodies if common sites are predicted, or through mobility shift assays on Phos-tag™ gels followed by Western blotting with SPCC1494.09c antibody . Immunoprecipitation of SPCC1494.09c followed by mass spectrometry analysis provides comprehensive PTM mapping. For functional studies, mutagenesis of predicted modification sites (e.g., changing serine/threonine to alanine for phosphorylation studies) coupled with phenotypic analysis reveals their biological significance. Co-immunoprecipitation experiments can identify interactions with modification enzymes such as kinases or ubiquitin ligases. When studying SUMOylation, specialized protocols incorporating N-ethylmaleimide in lysis buffers prevent SUMO deconjugation . Proximity ligation assays combining SPCC1494.09c antibody with antibodies against specific modifications offer in situ visualization of modified protein subpopulations with high sensitivity.

How can I integrate SPCC1494.09c antibody-based approaches with genetic screens in S. pombe?

Integrating antibody-based approaches with genetic screens creates powerful experimental frameworks for studying SPCC1494.09c function. Synthetic genetic array (SGA) methodology can identify genetic interactions by crossing SPCC1494.09c mutants with genome-wide deletion libraries, followed by Western blotting to examine how these interactions affect protein levels or modifications . For mechanistic insights, suppressors identified through genetic screens can be analyzed for their effects on SPCC1494.09c localization or interaction partners using immunofluorescence and co-immunoprecipitation . ChIP-seq with SPCC1494.09c antibody can be performed in genetic backgrounds that modify SPCC1494.09c function to understand context-dependent genomic associations. Multicopy suppressor screens, as described for TSC pathway components, can identify proteins that functionally interact with SPCC1494.09c when overexpressed . Finally, combining CRISPR-Cas9 genome editing to create specific SPCC1494.09c alleles with subsequent antibody-based biochemical characterization provides precise correlation between genetic and molecular phenotypes.

What are the recommended methods for expressing recombinant SPCC1494.09c for antibody production?

For generating optimal immunogens for SPCC1494.09c antibody production, recombinant protein expression in bacterial systems offers several advantages. The entire coding region of SPCC1494.09c should be PCR-amplified using high-fidelity polymerase with primers containing appropriate restriction sites (e.g., BamHI and SalI) for cloning into expression vectors such as pET-30-a, which provides a His-tag for purification . After transformation into E. coli expression strains like Tuner or BL21(DE3), induction conditions should be optimized (typically 0.5-1mM IPTG at 18-30°C) to maximize protein solubility. Purification using metal affinity systems such as MagneHis Protein Purification System yields suitable material for immunization . For difficult-to-express proteins, alternative approaches include expressing discrete domains of SPCC1494.09c or synthesizing KLH-conjugated peptides from regions predicted to be immunogenic. Quality control of purified immunogens should include SDS-PAGE with Coomassie staining to verify purity and mass spectrometry to confirm protein identity.

What specialized techniques exist for studying SPCC1494.09c interactions with chromatin or RNA?

For investigating SPCC1494.09c interactions with chromatin or RNA, specialized techniques have been developed that extend standard antibody applications. If SPCC1494.09c is suspected to interact with chromatin, ChIP-seq protocols can map genome-wide binding patterns, utilizing 2-5μg of antibody per immunoprecipitation reaction . For higher resolution, CUT&RUN or CUT&Tag techniques offer advantages by performing antibody-directed cleavage in situ without crosslinking. If SPCC1494.09c functions in RNA metabolism (like the related arz1 protein), RNA immunoprecipitation (RIP) using the antibody can identify associated transcripts . More sophisticated techniques include CLIP-seq (crosslinking immunoprecipitation followed by sequencing), which precisely maps RNA binding sites through UV crosslinking before immunoprecipitation with SPCC1494.09c antibody. For studying dynamic interactions, chromatin immunoprecipitation combined with exonuclease treatment (ChIP-exo) provides near-nucleotide resolution of binding sites. These advanced techniques should include appropriate controls, such as non-specific IgG immunoprecipitations and validation of enriched regions by independent methods.